Literature DB >> 19755476

Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.

Detlef H Krieter1, Andrea Hackl, Annie Rodriguez, Leïla Chenine, Hélène Leray Moragues, Horst-Dieter Lemke, Christoph Wanner, Bernard Canaud.   

Abstract

BACKGROUND: The accumulation of larger and protein-bound toxins is involved in the uraemic syndrome but their elimination by dialysis therapy remains difficult. In the present study, the impact of the albumin permeability of recently introduced advanced high-flux dialysis membranes on the removal of such substances was tested in haemodialysis and online post-dilution haemodiafiltration.
METHODS: Two types of polyethersulfone membranes only differing in albumin permeability (referred as PU- and PU+) were compared in eight patients on maintenance dialysis in a prospective cross-over manner. Treatment settings were identical for individual patients: time 229 +/- 22 min; blood flow rate 378 +/- 33 mL/min; dialysate flow rate 500 mL/min; substitution flow rate in haemodiafiltration 94 +/- 9 mL/min. Removal of the protein-bound compounds p-cresyl sulfate (pCS) and indoxyl sulfate (IS) was determined by reduction ratios (RRs), dialytic clearances and mass in continuously collected dialysate. In addition, the elimination of the low-molecular weight (LMW) proteins beta(2)-microglobulin, cystatin c, myoglobin (myo), free retinol-binding protein (rbp) and albumin was measured.
RESULTS: Plasma levels of the protein-bound toxins were significantly decreased by all treatment forms. However, the decreases were comparable between dialysis membranes and between haemodialysis and haemodiafiltration. The RRs of total pCS ranged between 40.4 +/- 25.3 and 47.8 +/- 10.3% and of total IS between 50.4 +/- 2.6 and 54.6 +/- 8.7%. Elimination of free protein-bound toxins as assessed by their mass in dialysate closely correlated positively with the pre-treatment plasma concentrations being r = 0.920 (P < 0.001) for total pCS and r = 0.906 (P < 0.001) for total IS, respectively. Compared to haemodialysis, much higher removal of all LMW proteins was found in haemodiafiltration. Dialysis membrane differences were only obvious in haemodialysis for the larger LMW proteins myo and rbp yielding significantly higher RRs for PU+ (myo 46 +/- 9 versus 37 +/- 9%; rbp 18 +/- 5 versus 15 +/- 5%; P < 0.05). Additionally, the albumin loss varied between membranes and treatment modes being undetectable with PU- in haemodialysis and highest with PU+ in haemodiafiltration (1430 +/- 566 mg).
CONCLUSIONS: The elimination of protein-bound compounds into dialysate is predicted by the level of pre-treatment plasma concentrations and depends particularly on diffusion. Lacking enhanced removal in online post-dilution haemodiafiltration emphasizes the minor significance of convection for the clearance of these solutes. Compared to LMW proteins, the highly protein-bound toxins pCS and IS are less effectively eliminated with all treatment forms. For a sustained decrease of pCS and IS plasma levels, alternative strategies promise to be more efficient therapy forms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19755476     DOI: 10.1093/ndt/gfp437

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  48 in total

Review 1.  Enhancing dialyser clearance-from target to development.

Authors:  Kamonwan Tangvoraphonkchai; Andrew Davenport
Journal:  Pediatr Nephrol       Date:  2017-04-12       Impact factor: 3.714

2.  p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease.

Authors:  Cheng-Jui Lin; Han-Hsiang Chen; Chi-Feng Pan; Chih-Kuang Chuang; Tuen-Jen Wang; Fang-Ju Sun; Chih-Jen Wu
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

Review 3.  Why choose high volume online post-dilution hemodiafiltration?

Authors:  Carlo Basile; Andrew Davenport; Peter J Blankestijn
Journal:  J Nephrol       Date:  2016-09-01       Impact factor: 3.902

4.  Plasma p-cresol lowering effect of sevelamer in non-dialysis CKD patients: evidence from a randomized controlled trial.

Authors:  Eleonora Riccio; Massimo Sabbatini; Dario Bruzzese; Lucia Grumetto; Cristina Marchetiello; Maria Amicone; Michele Andreucci; Bruna Guida; Davide Passaretti; Giacomo Russo; Antonio Pisani
Journal:  Clin Exp Nephrol       Date:  2017-11-20       Impact factor: 2.801

5.  A Renal Clinician's Guide to the Gut Microbiota.

Authors:  Matthew Snelson; Annabel Biruete; Catherine McFarlane; Katrina Campbell
Journal:  J Ren Nutr       Date:  2020-01-09       Impact factor: 3.655

6.  Long term variation of serum levels of uremic toxins in patients treated by post-dilution high volume on-line hemodiafiltration in comparison to standard low-flux bicarbonate dialysis: results from the REDERT study.

Authors:  Vincenzo Panichi; Maria Teresa Rocchetti; Alessia Scatena; Alberto Rosati; Massimiliano Migliori; Francesco Pizzarelli; Loreto Gesualdo
Journal:  J Nephrol       Date:  2017-03-24       Impact factor: 3.902

7.  p-Cresyl sulfate promotes insulin resistance associated with CKD.

Authors:  Laetitia Koppe; Nicolas J Pillon; Roxane E Vella; Marine L Croze; Caroline C Pelletier; Stéphane Chambert; Ziad Massy; Griet Glorieux; Raymond Vanholder; Yann Dugenet; Hédi A Soula; Denis Fouque; Christophe O Soulage
Journal:  J Am Soc Nephrol       Date:  2013-01       Impact factor: 10.121

Review 8.  High-flux versus low-flux membranes for end-stage kidney disease.

Authors:  Suetonia C Palmer; Kannaiyan S Rabindranath; Jonathan C Craig; Paul J Roderick; Francesco Locatelli; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

9.  Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.

Authors:  Magdalena Madero; Karla B Cano; Israel Campos; Xia Tao; Vaibhav Maheshwari; Jillian Brown; Beatriz Cornejo; Garry Handelman; Stephan Thijssen; Peter Kotanko
Journal:  Clin J Am Soc Nephrol       Date:  2019-02-12       Impact factor: 8.237

10.  Cationic uremic toxins affect human renal proximal tubule cell functioning through interaction with the organic cation transporter.

Authors:  Carolien M S Schophuizen; Martijn J Wilmer; Jitske Jansen; Lena Gustavsson; Constanze Hilgendorf; Joost G J Hoenderop; Lambert P van den Heuvel; Rosalinde Masereeuw
Journal:  Pflugers Arch       Date:  2013-06-29       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.